Acta Gastroenterologica Latinoamericana
Semaglutide and Metabolic Dysfunction-Associated Fatty Liver Disease: A Systematic Review
Systematic review of randomised trialsInterventions
- Semaglutide
- GLP-1 and incretin signalling
- Metabolic dysfunction-associated fatty liver disease
- Metabolic dysfunction-associated steatohepatitis
- Liver stiffness
- Humans
The paper
Hospital Italiano de Buenos Aires; National University of Formosa
Acta Gastroenterologica Latinoamericana, 31 Mar 2026
